Lvov; Vyacheslav Leonidovich

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lvov; Vyacheslav Leonidovich.The latest application filed is for "modified endotoxic bacteria lipopolysaccharide (variants), combination of modified lipopolysaccharides (variants) and, containing same, a vaccine (variants) and a pharmaceutical composition (variants)".

Company Profile

0.4.9

Lvov; Vyacheslav Leonidovich - Moscow N/A RU

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modified endotoxic bacteria lipopolysaccharide (variants), combination of modified lipopolysaccharides (variants) and, containing same, a vaccine (variants) and a pharmaceutical composition (variants) Grant 11,052,142 - Aparin , et al. July 6, 2	2021-07-06
Modified Endotoxic Bacteria Lipopolysaccharide (variants), Combination Of Modified Lipopolysaccharides (variants) And, Containing Same, A Vaccine (variants) And A Pharmaceutical Composition (variants) App 20180043004 - APARIN; Petr Gennadievich ; et al.	2018-02-15
Modified Endotoxic Bacteria Lipopolysaccharide (variants), Combination Of Modified Lipopolysaccharides (variants) And, Containing Same, A Vaccine (variants) And A Pharmaceutical Composition (variants) App 20160120967 - APARIN; Petr Gennadievich ; et al.	2016-05-05
Exopolysaccharide of Shigella sonnei bacteria, method for producing same, vaccine and phamaceutical composition containing same Grant 8,951,538 - Aparin , et al. February 10, 2	2015-02-10
Exopolysaccharide Of Shigella Sonnei Bacteria, Method For Producing Same, Vaccine And Pharmaceutical Composition Containing Same App 20140037687 - APARIN; Petr Gennadievich ; et al.	2014-02-06
Exopolysaccharide Of Shigella Sonnei Bacteria, Method For Producing Same, Vaccine And Pharmaceutical Composition Containing Same App 20130203980 - Aparin; Petr Gennadievich ; et al.	2013-08-08
Method of isolating biologically active fraction containing clinically acceptable native S-lipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides App 20040033550 - Aparin, Petr Gennadievich ; et al.	2004-02-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.